FAKTOR-OPTIONSSCHEIN - CEGEDIM Share Price

Certificat

DE000MA4SVA3

Market Closed - Börse Stuttgart 08:39:42 30/05/2024 pm IST
1.98 EUR +2.06% Intraday chart for FAKTOR-OPTIONSSCHEIN - CEGEDIM
Current month-4.43%
1 month-0.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Chart CEGEDIM
Chart FAKTOR-OPTIONSSCHEIN - CEGEDIM
Date Price Change
30/24/30 1.98 +2.06%
29/24/29 1.94 +1.04%
28/24/28 1.92 +1.59%
27/24/27 1.89 +6.78%
24/24/24 1.77 -4.32%

Delayed Quote Börse Stuttgart

Last update May 30, 2024 at 08:39 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CEGEDIM
Issuer Morgan Stanley
WKN MA4SVA
ISINDE000MA4SVA3
Date issued 28/01/2021
Strike 7.076
Maturity Unlimited
Parity 3.6 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.54
Lowest since issue 1.52
Spread 0.05
Spread %2.46%

Company Profile

Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (72.1%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (26.8%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (1.1%). France accounts for 89.7% of net sales.
Sector
-
More about the company

Ratings for Cegedim

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Cegedim

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
14.15 EUR
Average target price
18.03 EUR
Spread / Average Target
+27.44%
Consensus